Our data are supported by studies in which decreased levels or total loss of TGF-β signaling via defects of TGF-β receptors or Smads resulted in inflammation and uncontrolled proliferation of epithelial cells while promoting tumor development [26], [36], [47]. The gene discussed is TGFB1; the disease is neoplasm.